Monday, July 14, 2008

Alnylam Provides Update on "Glover" Patent - WELT ONLINE

Alnylam Provides Update on "Glover" Patent
WELT ONLINE, Germany - Jul 10, 2008
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the Glover patent (EP 1230375), which is exclusively ...

Source: http://news.google.com/news/url?sa=T&ct=us/9-0&fd=R&url=http://newsticker.welt.de/index.php%3Fchannel%3Dfin%26module%3Dsmarthouse%26id%3D751995&cid=1226975324&ei=5jl7SIqIL5_K8ATg94ixBg&usg=AFQjCNF-dXa1c6NcHX-le3N0U97azxLXvQ

No comments: